Stay updated on MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial

Sign up to get notified when there's something new on the MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:45:38.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision history updated: added Revision v3.5.0 and removed Revision v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T21:57:02.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.4.2 to v3.4.3, replacing the previous version.
    Difference
    0.1%
    Check dated 2026-03-12T19:28:16.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2, replacing v3.4.1, indicating a platform update with no substantive changes to study information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:28:58.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-04T23:47:04.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Show glossary was added and labels were updated to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with standardized capitalization. 'Revision: v3.4.0' was added and 'Revision: v3.3.4' was removed.
    Difference
    0.2%
    Check dated 2026-01-28T21:28:38.000Z thumbnail image

Stay in the know with updates to MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial page.